Faron

Faron

Pharmaceutical Manufacturing Turku, Fi 54 employees FARON
Employees
54
Contacts
1
Emails
1
Phones
1

Faron Overview

Headquarters
Turku, Fi
Phone Number
Available in AeroLeads
Website
faron.com
Industry
Pharmaceutical Manufacturing
Employees
54
Founded
2007
Stock Symbol
FARON
Funding
1.5M
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Faron

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. Its lead program is bexmarilimab, its investigative precision immunotherapy in Phase I/II development as a novel macrophage checkpoint immunotherapy for patients with hematological malignancies. Bexmarilimab is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Faron is based in Turku, Finland and Boston, Massachusetts. Faron is listed on AIM under the ticker ‘FARN’ and Nasdaq First North Growth Market ("Nasdaq First North") under ticker FARON.

Faron Contact Details

People in AeroLeads
2
With contact data
1
Email contacts
1
50.0% coverage
Phone contacts
1
50.0% coverage

Faron Org Chart

Sample employees and titles
Name Title Contact
Kaisa Kyttä Deputy General Counsel at Faron
View
Markku Jalkanen CEO at Faron Pharmaceuticals
Email Phone

Employees by Management Level

Director 2 profiles
Individual contributor 2 profiles
Executive 1 profile
VP / Head 1 profile
Manager 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0
Healthcare 1 1 0
Executive 1 1 0

Compare Similar Companies to Faron